Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.

× No keyword cloud information.

21 in total

1. Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations.

Authors: Julian G Hurdle; Amy E Heathcott; Lei Yang; Bing Yan; Richard E Lee
Journal: J Antimicrob Chemother Date: 2011-05-31 Impact factor: 5.790

2. Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors: Nuntra Suwantarat; David A Bobak
Journal: Curr Infect Dis Rep Date: 2011-02 Impact factor: 3.725

Review 3. Recurrent Clostridium difficile infection: what are the treatment options?

Authors: Claire M F van Nispen tot Pannerden; Annelies Verbon; Ernst J Kuipers
Journal: Drugs Date: 2011-05-07 Impact factor: 9.546

4. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.

Authors: Young Kyung Yoon; Min Ja Kim; Jang Wook Sohn; Hye Suk Kim; Yoon Ji Choi; Jung Sun Kim; Seung Tae Kim; Kyong Hwa Park; Seok Jin Kim; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Yong Park
Journal: Support Care Cancer Date: 2014-03-05 Impact factor: 3.603

Review 5. Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors: Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal: Eur J Clin Microbiol Infect Dis Date: 2018-11-29 Impact factor: 3.267

Review 6. The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Authors: E R Dubberke; D B Haslam; C Lanzas; L D Bobo; C-A D Burnham; Y T Gröhn; P I Tarr
Journal: Zoonoses Public Health Date: 2010-09-24 Impact factor: 2.702

Review 7. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors: Carey-Ann D Burnham; Karen C Carroll
Journal: Clin Microbiol Rev Date: 2013-07 Impact factor: 26.132

The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.